Evidence map›Paper›PMID 37630508›Full record

ArticleMicroorganisms2023

Correlation of CRISPR/Cas and Antimicrobial Resistance in

Amany K Alkompoz, Samira M Hamed, Ahmed S Abu Zaid, Thamer A Almangour, Mohamed H Al-Agamy, Khaled M Aboshanab

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Clonal Dissemination of Pandrug-ResistantInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Amany K AlkompozNational Food Safety Authority (NFSA), Giza 11361, Egypt.
Samira M HamedDepartment of Microbiology and Immunology, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), 6th of October, Giza 12451, Egypt.ORCID 0000-0003-2387-5814
Ahmed S Abu ZaidDepartment of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
Thamer A AlmangourDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0003-1508-8693
Mohamed H Al-AgamyDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-9868-0355
Khaled M AboshanabDepartment of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.ORCID 0000-0002-7608-850X
Ain Shams University · EGAl-Azhar University · EGKing Saud University · SANational Telecommunication Regulatory Authority · EGOctober University of Modern Sciences and Arts · EG

Funding

Deanship of Scientific Research at King Saud University RGP-038
6 · The paper itself

Abstract

The CRISPR/Cas system has been long known to interfere with the acquisition of foreign genetic elements and was recommended as a tool for fighting antimicrobial resistance. The current study aimed to explore the prevalence of the CRISPR/Cas system in

Indexed as

antimicrobial resistanceCRISPR/CasI-EI-E*Klebsiella pneumoniaeplasmidsspacersWGS

Identifiers

PMID37630508
PMCPMC10459600
OpenAlexW4385423508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.